The Foundation for Sarcoidosis Research's Cardiac Sarcoidosis Grant funds innovative studies to advance the understanding, diagnosis, and care of cardiac sarcoidosis.
Funder: Foundation for Sarcoidosis Research
Due Dates: June 4, 2026 (Letter of Intent) | September 14, 2026 (Full application)
Funding Amounts: $100,000 total per award over 2 years; up to 10% indirect costs permitted.
Summary: Supports innovative research to advance understanding, diagnosis, and care of cardiac sarcoidosis, with emphasis on FSR’s research priorities and patient-centered outcomes.
Key Information: LOI required via ProposalCentral; only invited applicants may submit full proposals.
This opportunity from the Foundation for Sarcoidosis Research (FSR) funds research projects dedicated to advancing the understanding, diagnosis, and treatment of cardiac sarcoidosis. The grant encourages both new and ongoing studies that address key challenges in the field, such as standardizing patient-centered outcomes, identifying disease biomarkers, improving diagnostic methods, and enhancing patient care quality. Proposals should align with FSR’s strategic priorities, which emphasize high-quality data, health equity, real-world evidence, and integration of patient perspectives. Multidisciplinary collaborations and investigator development are strongly encouraged.